A carregar...

Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids

PURPOSE: This study aimed to develop a hydrogel system for treating aggressive triple negative breast cancer (TNBC) via kinetically-controlled delivery of the synergistic drug pair doxorubicin (DOX) and gemcitabine (GEM). A 2D assay was adopted to evaluate therapeutic efficacy by determining combina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Res
Main Authors: Schneible, John D., Young, Ashlyn T., Daniele, M. A., Menegatti, S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983306/
https://ncbi.nlm.nih.gov/pubmed/32661774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-02864-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!